Mark Kong CFA Profile - DBS Analyst
11 Followers
Mark Kong CFA's Stock Coverage
| 9969InnoCare Pharma Ltd. | Nov 09, 2026 | BUY | Reiterated | HK$18.30 | 2Ratings | +3.80% | ||
| 3692Hansoh Pharmaceutical Group Company Limited | Oct 30, 2026 | BUY | Initiated | HK$46.00 | 1Ratings | +7.50% | ||
| 6160BeOne Medicines Ltd | Sep 28, 2026 | BUY | Reiterated | HK$290.00 | 5Ratings | +13.60% | ||
| 1681Consun Pharmaceutical Group Ltd. | Sep 17, 2026 | BUY | Reiterated | HK$26.00 | 6Ratings | +58.37% | ||
| 1801Innovent Biologics | Sep 15, 2026 | BUY | Reiterated | HK$144.00 | 3Ratings | -10.25% | ||
| 1093CSPC Pharmaceutical Group | Sep 10, 2026 | BUY | Initiated | HK$13.70 | 1Ratings | +6.80% | ||
| 1177Sino Biopharmaceutical | May 20, 2026 | BUY | Initiated | HK$6.50 | 1Ratings | -4.70% | ||
| 2105Laekna, Inc. | Mar 20, 2026 | BUY | Reiterated | HK$24.16 | 6Ratings | -56.34% | ||
| 1099Sinopharm Group Co | Dec 12, 2024 | BUY | Upgraded | HK$25.00 | 1Ratings | -0.20% | ||
| SNYSanofi | Oct 11, 2024 | BUY | Reiterated | ― | 1Ratings | -9.70% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Mark Kong CFA activity FAQ
What is the performance of Mark Kong CFA's recommendations?
The percentage of profitable recommendations made by Mark Kong CFA is 45.45%, and the average return per transaction is 0.60%.
What stocks does Mark Kong CFA cover?
Mark Kong CFA mostly covers InnoCare Pharma Ltd., Hansoh Pharmaceutical Group Company Limited, BeOne Medicines Ltd stocks.
What was Mark Kong CFA's most profitable rating?
Mark Kong CFA’s most profitable rating was a buy on Consun Pharmaceutical Group Ltd. stock on Feb 27, 2025. The return on the trade was 124.30%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here